Novartis starts work on Russian manufacturing plant
Novartis has started work on a manufacturing plant in St Petersburg in the first stage of a $500m investment in the Russian pharmaceutical industry.
Novartis has started work on a manufacturing plant in St Petersburg in the first stage of a $500m investment in the Russian pharmaceutical industry.
CIToxLAB was officially launched this week, giving the preclinical research sector a new player with operations on both sides of the Atlantic.
Contract manufacturing organisation (CMO) Neuland Laboratories will showcase its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego, US later this week.
Medidata is to buy Clinical Force in a move that will add SaaS CTMS capabilities to its eClinical suite.
Watson Pharmaceuticals has initiated a $44m (€31m) expansion of its Utah R&D and manufacturing plant for transdermal patches and topical gels.
Social media can play a role in ensuring that medicines are safe, but regulatory input is needed according to the Drug Safety Alliance (DSA).